These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33387369)

  • 21. Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms.
    Katso RM; Pardo OE; Palamidessi A; Franz CM; Marinov M; De Laurentiis A; Downward J; Scita G; Ridley AJ; Waterfield MD; Arcaro A
    Mol Biol Cell; 2006 Sep; 17(9):3729-44. PubMed ID: 16775008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods to measure the enzymatic activity of PI3Ks.
    Ciraolo E; Gulluni F; Hirsch E
    Methods Enzymol; 2014; 543():115-40. PubMed ID: 24924130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling by the phosphoinositide 3-kinase family in immune cells.
    Okkenhaug K
    Annu Rev Immunol; 2013; 31():675-704. PubMed ID: 23330955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells.
    Petiot A; Ogier-Denis E; Blommaart EF; Meijer AJ; Codogno P
    J Biol Chem; 2000 Jan; 275(2):992-8. PubMed ID: 10625637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoinositide switches in endocytosis and in the endolysosomal system.
    Wang H; Lo WT; Haucke V
    Curr Opin Cell Biol; 2019 Aug; 59():50-57. PubMed ID: 31029845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3K signalling in inflammation.
    Hawkins PT; Stephens LR
    Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of membrane traffic by phosphoinositide 3-kinases.
    Lindmo K; Stenmark H
    J Cell Sci; 2006 Feb; 119(Pt 4):605-14. PubMed ID: 16467569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.
    Maffucci T; Cooke FT; Foster FM; Traer CJ; Fry MJ; Falasca M
    J Cell Biol; 2005 Jun; 169(5):789-99. PubMed ID: 15928202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylinositol Kinases and Phosphatases in
    Nakada-Tsukui K; Watanabe N; Maehama T; Nozaki T
    Front Cell Infect Microbiol; 2019; 9():150. PubMed ID: 31245297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class I PI 3-kinases: Function and evolution.
    Kriplani N; Hermida MA; Brown ER; Leslie NR
    Adv Biol Regul; 2015 Sep; 59():53-64. PubMed ID: 26159297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted expression of the class II phosphoinositide 3-kinase in Drosophila melanogaster reveals lipid kinase-dependent effects on patterning and interactions with receptor signaling pathways.
    MacDougall LK; Gagou ME; Leevers SJ; Hafen E; Waterfield MD
    Mol Cell Biol; 2004 Jan; 24(2):796-808. PubMed ID: 14701751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylinositol 3 monophosphate metabolizing enzymes in blood platelet production and in thrombosis.
    Bellio M; Caux M; Vauclard A; Chicanne G; Gratacap MP; Terrisse AD; Severin S; Payrastre B
    Adv Biol Regul; 2020 Jan; 75():100664. PubMed ID: 31604685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways.
    Hawkins PT; Stephens LR
    Biochem Soc Trans; 2016 Feb; 44(1):307-14. PubMed ID: 26862220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K class IB pathway.
    Andrews S; Stephens LR; Hawkins PT
    Sci STKE; 2007 Oct; 2007(407):cm2. PubMed ID: 17925573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling.
    Curnock AP; Ward SG
    J Immunol Methods; 2003 Feb; 273(1-2):29-41. PubMed ID: 12535795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphoinositide conversion in endocytosis and the endolysosomal system.
    Wallroth A; Haucke V
    J Biol Chem; 2018 Feb; 293(5):1526-1535. PubMed ID: 29282290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
    Turner SJ; Domin J; Waterfield MD; Ward SG; Westwick J
    J Biol Chem; 1998 Oct; 273(40):25987-95. PubMed ID: 9748276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis.
    Valet C; Severin S; Chicanne G; Laurent PA; Gaits-Iacovoni F; Gratacap MP; Payrastre B
    Adv Biol Regul; 2016 May; 61():33-41. PubMed ID: 26714793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Form and flexibility in phosphoinositide 3-kinases.
    Williams R; Berndt A; Miller S; Hon WC; Zhang X
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):615-26. PubMed ID: 19614567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.